Growth Metrics

Mannkind (MNKD) Net Income Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 32.79%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 60.43%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -46.86%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.80%
7 Evaxion A 62.56 Bn 62.54 Bn - 19.97%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -3.84%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 47.10%
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn -19.27%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -19.27%
Dec 31, 2025 -5.20%
Sep 30, 2025 36.67%
Jun 30, 2025 26.47%
Mar 31, 2025 35.83%
Dec 31, 2024 31.31%
Sep 30, 2024 66.43%
Jun 30, 2024 61.73%
Mar 31, 2024 41.33%
Dec 31, 2023 27.10%
Sep 30, 2023 29.12%
Jun 30, 2023 19.92%
Mar 31, 2023 -1.66%
Dec 31, 2022 -10.22%
Sep 30, 2022 -11.65%
Jun 30, 2022 -32.82%
Mar 31, 2022 -20.43%
Dec 31, 2021 -57.20%
Sep 30, 2021 43.21%
Jun 30, 2021 -16.14%
Mar 31, 2021 24.81%
Dec 31, 2020 -32.51%
Sep 30, 2020 30.05%
Jun 30, 2020 33.80%
Mar 31, 2020 17.04%
Dec 31, 2019 -31.00%
Sep 30, 2019 -27.69%
Jun 30, 2019 25.50%
Mar 31, 2019 15.73%
Dec 31, 2018 -27.84%
Sep 30, 2018 8.80%
Jun 30, 2018 7.78%
Mar 31, 2018 0.30%
Dec 31, 2017 61.60%
Sep 30, 2017 3.43%
Jun 30, 2017 21.61%
Mar 31, 2017 32.06%
Dec 31, 2016 44.34%
Sep 30, 2016 64.97%
Jun 30, 2016 13.40%
Mar 31, 2016 15.32%
Dec 31, 2015 52.76%
Sep 30, 2015 9.40%
Jun 30, 2015 7.54%
Mar 31, 2015 7.05%
Dec 31, 2014 -0.04%
Sep 30, 2014 1.66%
Jun 30, 2014 -18.15%
Mar 31, 2014 -7.83%
Dec 31, 2013 -11.84%
Sep 30, 2013 -3.90%
Jun 30, 2013 -2.97%